《中国肺动脉高压诊断与治疗指南（2021版）》解读——动脉性肺动脉高压的治疗

2022-03-01 中国医学科学院阜外医院心内科中国实用内科杂志

动脉性肺动脉高压（PAH）为恶性进展性疾病。随着PAH靶向药物的广泛应用，患者预后较前明显改善。在肺动脉高压中心确诊的PAH初始治疗患者，建议其接受一般治疗及支持治疗。其中，对于特发性PAH、药物相关

中文标题：

发布机构：

中国医学科学院阜外医院心内科

发布日期：

2022-03-01

简要介绍：

动脉性肺动脉高压（PAH）为恶性进展性疾病。随着PAH靶向药物的广泛应用，患者预后较前明显改善。在肺动脉高压中心确诊的PAH初始治疗患者，建议其接受一般治疗及支持治疗。其中，对于特发性PAH、药物相关性PAH和遗传性PAH患者应进行急性血管反应试验，评估应用钙通道阻滞剂治疗。急性血管反应试验阴性的PAH患者建议应用初始靶向药物联合治疗，高危患者建议联合静脉前列环素类药物。治疗3～6个月进行随访评估，若为低危状态应继续治疗并规律随访；若为中危状态，推荐联合使用靶向药物；若为高危状态，建议使用包括静脉注射前列环素类药物的联合治疗方案，并进行肺移植评估。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=70f4e1c002a03668, title=《中国肺动脉高压诊断与治疗指南（2021版）》解读——动脉性肺动脉高压的治疗, enTitle=, guiderFrom=中国实用内科杂志, authorId=0, author=, summary=动脉性肺动脉高压（PAH）为恶性进展性疾病。随着PAH靶向药物的广泛应用，患者预后较前明显改善。在肺动脉高压中心确诊的PAH初始治疗患者，建议其接受一般治疗及支持治疗。其中，对于特发性PAH、药物相关, cover=https://img.medsci.cn/20220403/1648999729492_5579292.jpg, journalId=0, articlesId=null, associationId=2599, associationName=中国医学科学院阜外医院心内科, associationIntro=中国医学科学院阜外医院心内科, copyright=0, guiderPublishedTime=Tue Mar 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">动脉性肺动脉高压（PAH）为恶性进展性疾病。随着PAH靶向药物的广泛应用，患者预后较前明显改善。在肺动脉高压中心确诊的PAH初始治疗患者，建议其接受一般治疗及支持治疗。其中，对于特发性PAH、药物相关性PAH和遗传性PAH患者应进行急性血管反应试验，评估应用钙通道阻滞剂治疗。急性血管反应试验阴性的PAH患者建议应用初始靶向药物联合治疗，高危患者建议联合静脉前列环素类药物。治疗3～6个月进行随访评估，若为低危状态应继续治疗并规律随访；若为中危状态，推荐联合使用靶向药物；若为高危状态，建议使用包括静脉注射前列环素类药物的联合治疗方案，并进行肺移植评估。 </span></p>, tagList=[TagDto(tagId=1179, tagName=肺动脉高压), TagDto(tagId=436193, tagName=动脉性肺动脉高压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4362, appHits=249, showAppHits=0, pcHits=673, showPcHits=4109, likes=0, shares=41, comments=5, approvalStatus=1, publishedTime=Mon Apr 04 15:26:00 CST 2022, publishedTimeString=2022-03-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Apr 03 23:27:57 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 04:24:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《中国肺动脉高压诊断与治疗指南（2021版）》解读——动脉性肺动脉高压的治疗.pdf)])

《中国肺动脉高压诊断与治疗指南（2021版）》解读——动脉性肺动脉高压的治疗.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2105664, encodeId=68fd2105664a4, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff94761917, createdName=pengweily, createdTime=Mon Dec 12 10:26:28 CST 2022, time=2022-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1214837, encodeId=7283121483e89, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:25:21 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212795, encodeId=831e1212e95e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:34:04 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208657, encodeId=c4c7120865e42, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09871504840, createdName=曹玉芝, createdTime=Mon Apr 04 22:23:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208544, encodeId=fe41120854452, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2926326271, createdName=3059321_3399, createdTime=Mon Apr 04 15:29:36 CST 2022, time=2022-04-04, status=1, ipAttribution=)]
2022-12-12 pengweily 来自北京

非常好

31 0
[GetPortalCommentsPageByObjectIdResponse(id=2105664, encodeId=68fd2105664a4, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff94761917, createdName=pengweily, createdTime=Mon Dec 12 10:26:28 CST 2022, time=2022-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1214837, encodeId=7283121483e89, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:25:21 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212795, encodeId=831e1212e95e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:34:04 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208657, encodeId=c4c7120865e42, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09871504840, createdName=曹玉芝, createdTime=Mon Apr 04 22:23:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208544, encodeId=fe41120854452, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2926326271, createdName=3059321_3399, createdTime=Mon Apr 04 15:29:36 CST 2022, time=2022-04-04, status=1, ipAttribution=)]
2022-04-26 su_yi_fei

学习

51 0
[GetPortalCommentsPageByObjectIdResponse(id=2105664, encodeId=68fd2105664a4, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff94761917, createdName=pengweily, createdTime=Mon Dec 12 10:26:28 CST 2022, time=2022-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1214837, encodeId=7283121483e89, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:25:21 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212795, encodeId=831e1212e95e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:34:04 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208657, encodeId=c4c7120865e42, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09871504840, createdName=曹玉芝, createdTime=Mon Apr 04 22:23:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208544, encodeId=fe41120854452, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2926326271, createdName=3059321_3399, createdTime=Mon Apr 04 15:29:36 CST 2022, time=2022-04-04, status=1, ipAttribution=)]
2022-04-20 ms8000000410919385

学习

46 0
[GetPortalCommentsPageByObjectIdResponse(id=2105664, encodeId=68fd2105664a4, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff94761917, createdName=pengweily, createdTime=Mon Dec 12 10:26:28 CST 2022, time=2022-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1214837, encodeId=7283121483e89, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:25:21 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212795, encodeId=831e1212e95e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:34:04 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208657, encodeId=c4c7120865e42, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09871504840, createdName=曹玉芝, createdTime=Mon Apr 04 22:23:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208544, encodeId=fe41120854452, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2926326271, createdName=3059321_3399, createdTime=Mon Apr 04 15:29:36 CST 2022, time=2022-04-04, status=1, ipAttribution=)]
2022-04-04 曹玉芝

受益

59 0
[GetPortalCommentsPageByObjectIdResponse(id=2105664, encodeId=68fd2105664a4, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fff94761917, createdName=pengweily, createdTime=Mon Dec 12 10:26:28 CST 2022, time=2022-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1214837, encodeId=7283121483e89, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:25:21 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212795, encodeId=831e1212e95e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:34:04 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208657, encodeId=c4c7120865e42, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09871504840, createdName=曹玉芝, createdTime=Mon Apr 04 22:23:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208544, encodeId=fe41120854452, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2926326271, createdName=3059321_3399, createdTime=Mon Apr 04 15:29:36 CST 2022, time=2022-04-04, status=1, ipAttribution=)]
2022-04-04 3059321_3399

学习

64 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

《中国肺动脉高压诊断与治疗指南（2021版）》解读——动脉性肺动脉高压的治疗

相关指南

科室

工具

服务